Rajeev Jayadevan
RajeevJayadevan
Evidence that B.1.617.2 (India) is a not a fatal variant. No deaths occurred from an outbreak of 15 cases in a UK care home. This group, being frail, has high
Read more
AstraZeneca Vaccine and clots: this important paper from Germany proves that VITT is not the result of cross-reactivity between anti-spike antibodies and platelet factor 4 (PF4). See thread and links
Read more
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor | Blood | Othman et al American Society of Hematology 2007 |1. Adenoviruses, when given intravenously as in gene therapy, may directly
Read more
Results announced by AstraZeneca today after analysing 11,636 people who received 2 regimes of vaccine. 2741 people got the 1/2 dose-full dose regimen taken 1 month apart: 90% efficacy 8895
Read more